butyric acid has been researched along with Colitis Gravis in 51 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients aged 6-18 years with colonic Crohn's disease or ulcerative colitis, who received standard therapy depending on the disease's severity, were randomized to receive 150 mg sodium butyrate twice a day (group A) or placebo (group B)." | 3.11 | Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases-Randomized Placebo-Controlled Multicenter Trial. ( Banasiuk, M; Banaszkiewicz, A; Borys-Iwanicka, A; Pietrzak, A; Pytrus, T; Szczepanik, M; Walkowiak, J, 2022) |
| "It has been suggested that ulcerative colitis is, at least in part, related to an energy deficiency state of the colonic mucosa which may be secondary to impaired short chain fatty acid production, uptake or utilization." | 2.68 | Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. ( Baker, JP; Brzezinski, A; Hiruki, T; Steinhart, AH, 1996) |
| "Tissue factor XIII activity in active ulcerative colitis was significantly lower than in mucosa from normal colons; however, it was not affected by SCFA or butyrate irrigation." | 2.68 | Histological changes in the colonic mucosa following irrigation with short-chain fatty acids. ( Bartram, HP; Boxberger, F; Christl, SU; Dempfle, CE; Dusel, G; Kasper, H; Müller, JG; Richter, F; Scheppach, W, 1997) |
| "It has been suggested that ulcerative colitis (UC) is, at least in part, related to an energy deficiency state of the colonic mucosa which may be secondary to impaired SCFA production, uptake, or utilization." | 2.67 | Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. ( Baker, JP; Brzezinski, A; Steinhart, AH, 1994) |
| "Although the exact cause of ulcerative colitis remains undetermined, the condition appears to be related to a combination of genetic and environmental factors." | 2.42 | Inflammatory bowel disease Part 1: ulcerative colitis--pathophysiology and conventional and alternative treatment options. ( Head, KA; Jurenka, JS, 2003) |
| "We induced ulcerative colitis (UC) in mice utilizing dextran sodium sulfate (DSS) in the drinking water for 7 days." | 1.91 | Sodium Butyrate Protects Against Intestinal Oxidative Damage and Neuroinflammation in the Prefrontal Cortex of Ulcerative Colitis Mice Model. ( De Oliveira, J; do Nascimento, ND; Fröhlich, NT; Gelain, DP; Gomes, HM; Kessler, F; Martins, A; Moreira, JCF; Paz, AH; Possa, L; Rodrigues, MS; Santos, L; Silveira, AK; Sirena, D, 2023) |
| "We found that ulcerative colitis (UC) induced an increase in prostate volumes that could be reversed by sodium butyrate (NaB) and fecal microbiota transplantation (FMT)." | 1.72 | Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement. ( Dong, W; Huang, Y; Jiang, X; Liang, X; Liu, H; Tan, H; Xu, H; Yang, S; Zeng, G; Zhang, Z; Zheng, J; Zhong, W, 2022) |
| "Colitis was induced by drinking 2% DSS for 7 days." | 1.72 | Intermittent Fasting Alleviates Risk Markers in a Murine Model of Ulcerative Colitis by Modulating the Gut Microbiome and Metabolome. ( Bian, X; Li, L; Li, Y; Man, D; Shi, D; Wang, K; Wang, Q; Wang, S; Wu, J; Wu, W; Yang, L, 2022) |
| "Ulcerative colitis is associated with a selective reduction of n-butyrate oxidation by the colonic epithelial cells although the reason for this has been unclear." | 1.30 | Thiolmethyltransferase activity in the human colonic mucosa: implications for ulcerative colitis. ( Babidge, WJ; Millard, SH; Moore, JW; Roediger, WE, 1997) |
| "Changes in ulcerative colitis were different from those in Crohn's disease (p = 0." | 1.29 | Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer. ( Gibson, P; Nov, R; Rosella, O; Young, G, 1995) |
| "Nine patients with distal ulcerative colitis refractory to standard therapy were treated with intrarectal instillation of a sodium butyrate solution and 5-ASA." | 1.29 | Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrate. ( Caprilli, R; Cittadini, M; Torsoli, A; Vernia, P, 1995) |
| "A hypothesis for the disease process of ulcerative colitis is that sulphides may form persulphides with butyryl-CoA, which would inhibit cellular short-chain acyl-CoA deHydrogenase and beta-oxidation to induce an energy-deficiency state in colonocytes and mucosal inflammation." | 1.29 | Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis? ( Duncan, A; Kapaniris, O; Millard, S; Roediger, WE, 1993) |
| "These data confirm that in quiescent ulcerative colitis there is an impairment of butyrate oxidation." | 1.29 | Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. ( Boyle, MA; Chapman, MA; Grahn, MF; Hutton, M; Rogers, J; Williams, NS, 1994) |
| "Colon cells from patients with ulcerative colitis utilize short-chain fatty acids inefficiently and may be exposed to decreased concentrations of these compounds." | 1.28 | Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. ( Bean, J; Breuer, RI; Buto, SK; Caprilli, R; Christ, ML; Di Paolo, MC; Paoluzi, P; Vernia, P, 1991) |
| "In acute ulcerative colitis, compared with controls, bicarbonate output and pH was reduced (p less than 0." | 1.27 | Colonic bicarbonate output as a test of disease activity in ulcerative colitis. ( Grant, AK; Kwok, V; Lawson, MJ; Pannall, PR; Roediger, WE, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.96) | 18.7374 |
| 1990's | 25 (49.02) | 18.2507 |
| 2000's | 4 (7.84) | 29.6817 |
| 2010's | 6 (11.76) | 24.3611 |
| 2020's | 15 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Li, W | 1 |
| Zhang, L | 1 |
| Xu, Q | 1 |
| Yang, W | 1 |
| Zhao, J | 1 |
| Ren, Y | 1 |
| Yu, Z | 1 |
| Ma, L | 1 |
| Chen, MJ | 1 |
| Feng, Y | 2 |
| Gao, L | 1 |
| Lin, MX | 1 |
| Wang, SD | 1 |
| Tong, ZQ | 1 |
| Pietrzak, A | 1 |
| Banasiuk, M | 1 |
| Szczepanik, M | 1 |
| Borys-Iwanicka, A | 1 |
| Pytrus, T | 1 |
| Walkowiak, J | 2 |
| Banaszkiewicz, A | 1 |
| Dong, W | 3 |
| Zheng, J | 3 |
| Huang, Y | 3 |
| Tan, H | 3 |
| Yang, S | 3 |
| Zhang, Z | 3 |
| Liang, X | 3 |
| Liu, H | 4 |
| Zeng, G | 3 |
| Xu, H | 3 |
| Jiang, X | 3 |
| Zhong, W | 3 |
| Wu, J | 2 |
| Man, D | 1 |
| Shi, D | 1 |
| Wu, W | 1 |
| Wang, S | 1 |
| Wang, K | 2 |
| Li, Y | 1 |
| Yang, L | 1 |
| Bian, X | 1 |
| Wang, Q | 2 |
| Li, L | 1 |
| Chen, Z | 1 |
| Nong, Y | 1 |
| Feng, L | 1 |
| He, Y | 1 |
| Guo, B | 1 |
| Qin, Y | 2 |
| Zhong, X | 1 |
| Qin, J | 1 |
| Wei, J | 1 |
| Dong, M | 1 |
| Pan, S | 1 |
| Su, Z | 1 |
| Bian, Z | 1 |
| Zhang, Q | 1 |
| Sun, X | 1 |
| Liu, L | 1 |
| Mao, L | 1 |
| Yan, Y | 1 |
| Liao, W | 1 |
| Zha, L | 1 |
| Sun, S | 1 |
| Haskey, N | 1 |
| Estaki, M | 1 |
| Ye, J | 1 |
| Shim, RK | 1 |
| Singh, S | 1 |
| Dieleman, LA | 1 |
| Jacobson, K | 1 |
| Gibson, DL | 1 |
| Liu, J | 1 |
| Fang, H | 1 |
| Hong, N | 1 |
| Lv, C | 1 |
| Zhu, Q | 1 |
| Wang, B | 1 |
| Tian, J | 1 |
| Yu, Y | 1 |
| Ikeda, Y | 1 |
| Matsuda, S | 1 |
| Caetano, MAF | 1 |
| Magalhães, HIR | 1 |
| Duarte, JRL | 1 |
| Conceição, LB | 1 |
| Castelucci, P | 1 |
| Thomas, S | 1 |
| Dilbarov, N | 1 |
| Kelly, J | 1 |
| Mercogliano, G | 1 |
| Prendergast, GC | 1 |
| Silveira, AK | 1 |
| Gomes, HM | 1 |
| Fröhlich, NT | 1 |
| Possa, L | 1 |
| Santos, L | 1 |
| Kessler, F | 1 |
| Martins, A | 1 |
| Rodrigues, MS | 1 |
| De Oliveira, J | 1 |
| do Nascimento, ND | 1 |
| Sirena, D | 1 |
| Paz, AH | 1 |
| Gelain, DP | 1 |
| Moreira, JCF | 1 |
| Zhang, F | 1 |
| Wang, W | 1 |
| Niu, J | 1 |
| Yang, G | 1 |
| Luo, J | 1 |
| Lan, D | 1 |
| Li, M | 1 |
| Sun, Y | 1 |
| Miao, Y | 1 |
| Jamka, M | 1 |
| Kokot, M | 1 |
| Kaczmarek, N | 1 |
| Bermagambetova, S | 1 |
| Nowak, JK | 1 |
| Laserna-Mendieta, EJ | 1 |
| Clooney, AG | 1 |
| Carretero-Gomez, JF | 1 |
| Moran, C | 1 |
| Sheehan, D | 1 |
| Nolan, JA | 1 |
| Hill, C | 1 |
| Gahan, CGM | 1 |
| Joyce, SA | 1 |
| Shanahan, F | 1 |
| Claesson, MJ | 1 |
| Khalil, NA | 1 |
| Walton, GE | 1 |
| Gibson, GR | 1 |
| Tuohy, KM | 1 |
| Andrews, SC | 1 |
| Machiels, K | 1 |
| Joossens, M | 1 |
| Sabino, J | 1 |
| De Preter, V | 1 |
| Arijs, I | 1 |
| Eeckhaut, V | 1 |
| Ballet, V | 1 |
| Claes, K | 1 |
| Van Immerseel, F | 1 |
| Verbeke, K | 1 |
| Ferrante, M | 1 |
| Verhaegen, J | 1 |
| Rutgeerts, P | 1 |
| Vermeire, S | 1 |
| Malago, JJ | 1 |
| Sangu, CL | 1 |
| Assisi, RF | 1 |
| Yoshida, T | 1 |
| Sekine, T | 1 |
| Aisaki, K | 1 |
| Mikami, T | 1 |
| Kanno, J | 1 |
| Okayasu, I | 2 |
| Rieder, F | 1 |
| Karrasch, T | 1 |
| Ben-Horin, S | 1 |
| Schirbel, A | 1 |
| Ehehalt, R | 1 |
| Wehkamp, J | 1 |
| de Haar, C | 1 |
| Velin, D | 1 |
| Latella, G | 2 |
| Scaldaferri, F | 1 |
| Rogler, G | 1 |
| Higgins, P | 1 |
| Sans, M | 1 |
| Ariake, K | 1 |
| Ohkusa, T | 2 |
| Sakurazawa, T | 1 |
| Kumagai, J | 1 |
| Eishi, Y | 1 |
| Hoshi, S | 1 |
| Yajima, T | 1 |
| Ogihara, T | 1 |
| Morita, K | 1 |
| Ogawa, M | 1 |
| Sato, N | 1 |
| Head, KA | 1 |
| Jurenka, JS | 1 |
| Roediger, WE | 7 |
| Lawson, MJ | 1 |
| Kwok, V | 1 |
| Grant, AK | 1 |
| Pannall, PR | 1 |
| Johnson, IT | 1 |
| Gibson, P | 1 |
| Rosella, O | 1 |
| Nov, R | 1 |
| Young, G | 1 |
| Vernia, P | 3 |
| Marcheggiano, A | 1 |
| Caprilli, R | 4 |
| Frieri, G | 1 |
| Corrao, G | 1 |
| Valpiani, D | 1 |
| Di Paolo, MC | 2 |
| Paoluzi, P | 2 |
| Torsoli, A | 2 |
| Anderson, FH | 1 |
| Cittadini, M | 1 |
| Soergel, KH | 1 |
| Millard, S | 3 |
| Finnie, IA | 2 |
| Dwarakanath, AD | 1 |
| Taylor, BA | 2 |
| Rhodes, JM | 2 |
| Frankel, W | 1 |
| Lew, J | 1 |
| Su, B | 1 |
| Bain, A | 1 |
| Klurfeld, D | 1 |
| Einhorn, E | 1 |
| MacDermott, RP | 1 |
| Rombeau, J | 1 |
| Duncan, A | 1 |
| Kapaniris, O | 1 |
| Steinhart, AH | 2 |
| Brzezinski, A | 2 |
| Baker, JP | 2 |
| Chapman, MA | 2 |
| Grahn, MF | 2 |
| Boyle, MA | 1 |
| Hutton, M | 2 |
| Rogers, J | 1 |
| Williams, NS | 2 |
| Patz, J | 1 |
| Jacobsohn, WZ | 1 |
| Gottschalk-Sabag, S | 1 |
| Zeides, S | 1 |
| Braverman, DZ | 1 |
| Babidge, W | 1 |
| Hiruki, T | 1 |
| Scheppach, W | 2 |
| Müller, JG | 1 |
| Boxberger, F | 1 |
| Dusel, G | 2 |
| Richter, F | 2 |
| Bartram, HP | 1 |
| Christl, SU | 1 |
| Dempfle, CE | 1 |
| Kasper, H | 2 |
| Moore, JW | 1 |
| Babidge, WJ | 1 |
| Millard, SH | 1 |
| Johnson, JA | 1 |
| Sommer, H | 1 |
| Kirchner, T | 1 |
| Paganelli, GM | 1 |
| Bartram, P | 1 |
| Christl, S | 1 |
| Breuer, RI | 1 |
| Buto, SK | 1 |
| Christ, ML | 1 |
| Bean, J | 1 |
| Nance, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Antimicrobial Therapy for Ulcerative Colitis : Evaluation of Two Antibiotic Combinations for Refractory Ulcerative Colitis[NCT03986996] | Phase 2 | 20 participants (Actual) | Interventional | 2019-07-25 | Terminated (stopped due to There is no feasibility to conduct the study) | ||
| Tolerability and Risk of Adverse Events With a Probiotic Supplement: A Randomised and Placebo Controlled Study in Healthy Individuals[NCT03728868] | 50 participants (Actual) | Interventional | 2018-10-10 | Completed | |||
| PediCRaFT: Pediatric Crohn's Disease Fecal Microbiota Transplant Pilot Study[NCT03378167] | Phase 1 | 17 participants (Actual) | Interventional | 2018-12-01 | Completed | ||
| Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease by Proteomic and Mass Cytometry Approaches[NCT03885713] | Phase 4 | 180 participants (Anticipated) | Interventional | 2019-09-10 | Recruiting | ||
| Transdermal Nicotine in Female Patients at High Risk for PONV[NCT00775749] | 0 participants (Actual) | Interventional | 2009-04-30 | Withdrawn (stopped due to The study is not feasible with the number of subjects needed to complete it.) | |||
| Effect of Gut Butyrate Delivery on Blood Pressure in African Americans With Hypertension[NCT04415333] | Phase 1 | 20 participants (Actual) | Interventional | 2021-07-08 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Blood biomarker samples were collected for the inflammatory cytokine IL-1β. (NCT04415333)
Timeframe: up to 1 hour post enema
| Intervention | pg/mL (Mean) |
|---|---|
| Sodium Butyrate [5 mmol] | NA |
| Sodium Butyrate [80 mmol] | NA |
| Control | NA |
Immediately following self-administration of butyrate enema, participants will be fitted with an ambulatory blood pressure monitor to be worn for 24 hours. (NCT04415333)
Timeframe: approximately 16 hours post enema
| Intervention | mmHg (Mean) |
|---|---|
| Sodium Butyrate [5 mmol] | 137.5 |
| Sodium Butyrate [80 mmol] | 132.9 |
| Control | 128.2 |
Immediately following self-administration of butyrate enema, participants will be fitted with an ambulatory blood pressure monitor to be worn for 24 hours. (NCT04415333)
Timeframe: approximately 8 hours post enema
| Intervention | mmHg (Mean) |
|---|---|
| Sodium Butyrate [5 mmol] | 123.2 |
| Sodium Butyrate [80 mmol] | 116.2 |
| Control | 114.0 |
Measure blood butyrate concentrations before, 30 minutes post, and 60 minutes post self-administration of the butyrate enemas (NCT04415333)
Timeframe: up to 1 hour post enema
| Intervention | ng/mL (Mean) |
|---|---|
| Baseline | |
| Control | 149.89 |
Measure blood butyrate concentrations before, 30 minutes post, and 60 minutes post self-administration of the butyrate enemas (NCT04415333)
Timeframe: up to 1 hour post enema
| Intervention | ng/mL (Mean) | |
|---|---|---|
| Baseline | 30 Minutes Post | |
| Sodium Butyrate [5 mmol] | 143.88 | 138.64 |
| Sodium Butyrate [80 mmol] | 138.60 | 151.57 |
5 reviews available for butyric acid and Colitis Gravis
| Article | Year |
|---|---|
The Effect of Sodium Butyrate Enemas Compared with Placebo on Disease Activity, Endoscopic Scores, and Histological and Inflammatory Parameters in Inflammatory Bowel Diseases: A Systematic Review of Randomised Controlled Trials.
Topics: Butyric Acid; Colitis, Ulcerative; Enema; Humans; Inflammatory Bowel Diseases; Randomized Controlled | 2021 |
Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, | 2012 |
Inflammatory bowel disease Part 1: ulcerative colitis--pathophysiology and conventional and alternative treatment options.
Topics: Butyric Acid; Colitis, Ulcerative; Diet; Elements; Fatty Acids; Humans; Nicotine; Nicotinic Agonists | 2003 |
Butyrate and markers of neoplastic change in the colon.
Topics: Alkaline Phosphatase; Biomarkers, Tumor; Butyrates; Butyric Acid; Cell Division; Colitis, Ulcerative | 1995 |
Metabolism of large bowel mucosa in health and disease.
Topics: Anaerobiosis; Butyrates; Butyric Acid; Colitis; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Di | 1991 |
9 trials available for butyric acid and Colitis Gravis
| Article | Year |
|---|---|
Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases-Randomized Placebo-Controlled Multicenter Trial.
Topics: Adolescent; Butyric Acid; Child; Colitis, Ulcerative; Crohn Disease; Humans; Inflammatory Bowel Dise | 2022 |
A Mediterranean Diet Pattern Improves Intestinal Inflammation Concomitant with Reshaping of the Bacteriome in Ulcerative Colitis: A Randomised Controlled Trial.
Topics: Adult; Butyric Acid; Canada; Colitis, Ulcerative; Diet, Mediterranean; Feces; Female; Humans; Inflam | 2023 |
Combined butyric acid/mesalazine treatment in ulcerative colitis with mild-moderate activity. Results of a multicentre pilot study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Butyric Acid; Colitis, Ulcerative; | 2008 |
Short-chain fatty acid topical treatment in distal ulcerative colitis.
Topics: Acetates; Acetic Acid; Adult; Butyrates; Butyric Acid; Colitis, Ulcerative; Double-Blind Method; Ene | 1995 |
Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas.
Topics: Adult; Aged; Butyrates; Butyric Acid; Colitis, Ulcerative; Enema; Female; Humans; Male; Middle Aged | 1994 |
Treatment of refractory distal ulcerative colitis with short chain fatty acid enemas.
Topics: Acetates; Acetic Acid; Adult; Butyrates; Butyric Acid; Case-Control Studies; Colitis, Ulcerative; En | 1996 |
Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial.
Topics: Adult; Aged; Butyrates; Butyric Acid; Colitis, Ulcerative; Colon; Enema; Female; Histone Deacetylase | 1996 |
Histological changes in the colonic mucosa following irrigation with short-chain fatty acids.
Topics: Adult; Biopsy; Butyrates; Butyric Acid; Colitis, Ulcerative; Enema; Factor XIII; Fatty Acids, Volati | 1997 |
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis.
Topics: Adult; Butyrates; Butyric Acid; Cell Division; Colitis, Ulcerative; Colon; Endoscopy; Enema; Female; | 1992 |
37 other studies available for butyric acid and Colitis Gravis
| Article | Year |
|---|---|
Taxifolin Alleviates DSS-Induced Ulcerative Colitis by Acting on Gut Microbiome to Produce Butyric Acid.
Topics: Animals; Butyric Acid; Colitis, Ulcerative; Dextran Sulfate; Gastrointestinal Microbiome; Mice; Quer | 2022 |
Composite Sophora Colon-Soluble Capsule Ameliorates DSS-Induced Ulcerative Colitis in Mice via Gut Microbiota-Derived Butyric Acid and NCR
Topics: Animals; Butyric Acid; Colitis; Colitis, Ulcerative; Colon; Disease Models, Animal; Gastrointestinal | 2023 |
Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement.
Topics: Animals; Butyric Acid; Colitis, Ulcerative; Fecal Microbiota Transplantation; Gastrointestinal Micro | 2022 |
Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement.
Topics: Animals; Butyric Acid; Colitis, Ulcerative; Fecal Microbiota Transplantation; Gastrointestinal Micro | 2022 |
Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement.
Topics: Animals; Butyric Acid; Colitis, Ulcerative; Fecal Microbiota Transplantation; Gastrointestinal Micro | 2022 |
Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement.
Topics: Animals; Butyric Acid; Colitis, Ulcerative; Fecal Microbiota Transplantation; Gastrointestinal Micro | 2022 |
Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement.
Topics: Animals; Butyric Acid; Colitis, Ulcerative; Fecal Microbiota Transplantation; Gastrointestinal Micro | 2022 |
Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement.
Topics: Animals; Butyric Acid; Colitis, Ulcerative; Fecal Microbiota Transplantation; Gastrointestinal Micro | 2022 |
Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement.
Topics: Animals; Butyric Acid; Colitis, Ulcerative; Fecal Microbiota Transplantation; Gastrointestinal Micro | 2022 |
Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement.
Topics: Animals; Butyric Acid; Colitis, Ulcerative; Fecal Microbiota Transplantation; Gastrointestinal Micro | 2022 |
Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement.
Topics: Animals; Butyric Acid; Colitis, Ulcerative; Fecal Microbiota Transplantation; Gastrointestinal Micro | 2022 |
Intermittent Fasting Alleviates Risk Markers in a Murine Model of Ulcerative Colitis by Modulating the Gut Microbiome and Metabolome.
Topics: Akkermansia; Animals; Bile Acids and Salts; Butyric Acid; Chromatography, Liquid; Colitis; Colitis, | 2022 |
Preventive effect of tilapia skin collagen hydrolysates on ulcerative colitis mice based on metabonomic and 16 S rRNA gene sequencing.
Topics: Acetic Acid; Actinobacteria; Animals; Bacteroidetes; Butyric Acid; Colitis; Colitis, Ulcerative; Col | 2023 |
Sodium Butyrate Inhibits Oxidative Stress and NF-κB/NLRP3 Activation in Dextran Sulfate Sodium Salt-Induced Colitis in Mice with Involvement of the Nrf2 Signaling Pathway and Mitophagy.
Topics: Animals; Butyric Acid; Colitis; Colitis, Ulcerative; Cyclooxygenase 2; Dextran Sulfate; Disease Mode | 2023 |
Gut Microbiome and Metabonomic Profile Predict Early Remission to Anti-Integrin Therapy in Patients with Moderate to Severe Ulcerative Colitis.
Topics: Butyric Acid; Colitis, Ulcerative; Gastrointestinal Microbiome; Humans; Integrins; Metabolomics; RNA | 2023 |
Gut Protective Effect from D-Methionine or Butyric Acid against DSS and Carrageenan-Induced Ulcerative Colitis.
Topics: Animals; Butyric Acid; Carrageenan; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, A | 2023 |
Butyrate Protects Myenteric Neurons Loss in Mice Following Experimental Ulcerative Colitis.
Topics: Animals; Butyric Acid; Colitis; Colitis, Ulcerative; Mice; Mice, Inbred C57BL; Neurons | 2023 |
Diet effects on colonic health influence the efficacy of Bin1 mAb immunotherapy for ulcerative colitis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Butyric Acid; Coleoptera; Colitis, Ulcerative; Diet, | 2023 |
Sodium Butyrate Protects Against Intestinal Oxidative Damage and Neuroinflammation in the Prefrontal Cortex of Ulcerative Colitis Mice Model.
Topics: Animals; Butyric Acid; Claudin-5; Colitis, Ulcerative; Disease Models, Animal; Inflammation; Inflamm | 2023 |
Heat-shock transcription factor 2 promotes sodium butyrate-induced autophagy by inhibiting mTOR in ulcerative colitis.
Topics: Adult; Animals; Autophagy; Butyric Acid; Colitis, Ulcerative; Enterocytes; Female; Heat-Shock Protei | 2020 |
Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn's Disease and Ulcerative Colitis.
Topics: Adult; Butyric Acid; Case-Control Studies; Clostridiales; Coenzyme A-Transferases; Colitis, Ulcerati | 2018 |
In vitro batch cultures of gut microbiota from healthy and ulcerative colitis (UC) subjects suggest that sulphate-reducing bacteria levels are raised in UC and by a protein-rich diet.
Topics: Amino Acids, Sulfur; Butyric Acid; Colitis, Ulcerative; Colon; Diet, Protein-Restricted; Dietary Pro | 2014 |
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Topics: Adult; Bacterial Load; Butyric Acid; Case-Control Studies; Colitis, Ulcerative; Denaturing Gradient | 2014 |
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Topics: Adult; Bacterial Load; Butyric Acid; Case-Control Studies; Colitis, Ulcerative; Denaturing Gradient | 2014 |
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Topics: Adult; Bacterial Load; Butyric Acid; Case-Control Studies; Colitis, Ulcerative; Denaturing Gradient | 2014 |
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Topics: Adult; Bacterial Load; Butyric Acid; Case-Control Studies; Colitis, Ulcerative; Denaturing Gradient | 2014 |
Intraperitoneal administration of butyrate prevents the severity of acetic acid colitis in rats.
Topics: Acetic Acid; Administration, Oral; Administration, Rectal; Animals; Butyric Acid; Colitis, Ulcerativ | 2015 |
CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid.
Topics: Apoptosis; Butyric Acid; Cell Line, Tumor; Colitis, Ulcerative; Colon; Genes, p53; Humans; Intestina | 2011 |
Roles of mucosal bacteria and succinic acid in colitis caused by dextran sulfate sodium in mice.
Topics: Acetates; Animals; Bacteroidaceae; Bacteroides; Butyric Acid; Carboxylic Acids; Cecum; Colitis; Coli | 2000 |
Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis.
Topics: Adult; Animals; Bacteriological Techniques; Butyric Acid; Colitis, Ulcerative; Colon; Female; Fusoba | 2003 |
Colonic bicarbonate output as a test of disease activity in ulcerative colitis.
Topics: Acute Disease; Bicarbonates; Butyrates; Butyric Acid; Colitis, Ulcerative; Colon; Dialysis; Humans; | 1984 |
Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Butyrates; Butyric Acid; Cell Dif | 1995 |
The rectal approach to treatment in distal ulcerative colitis.
Topics: Absorption; Administration, Rectal; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; B | 1995 |
Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrate.
Topics: Administration, Topical; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Butyr | 1995 |
Colonic fermentation: metabolic and clinical implications.
Topics: Acetates; Acetic Acid; Anaerobiosis; Animals; Butyrates; Butyric Acid; Cell Division; Colitis, Ulcer | 1994 |
Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis?
Topics: Aminosalicylic Acids; Animals; Butyrates; Butyric Acid; Carbon Dioxide; Cells, Cultured; Colitis, Ul | 1995 |
Colonic mucin synthesis is increased by sodium butyrate.
Topics: Adult; Aged; Butyrates; Butyric Acid; Caprylates; Chromatography, Agarose; Colitis, Ulcerative; Colo | 1995 |
Butyrate increases colonocyte protein synthesis in ulcerative colitis.
Topics: Aged; Butyrates; Butyric Acid; Cell Division; Cell Survival; Colitis, Ulcerative; Colon; Crohn Disea | 1994 |
Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism.
Topics: Adolescent; Adult; Aged; Butyrates; Butyric Acid; Colitis, Ulcerative; Colon; Culture Techniques; Ep | 1993 |
Colonic epithelial metabolism in ulcerative colitis.
Topics: Butyrates; Butyric Acid; Colitis, Ulcerative; Colon; Humans; Intestinal Mucosa | 1993 |
Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis?
Topics: Animals; Butyrates; Butyric Acid; Carbon Dioxide; Colitis, Ulcerative; Colon; Glucose; Ketone Bodies | 1993 |
Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis.
Topics: Adult; Aged; Butyrates; Butyric Acid; Colitis, Ulcerative; Colon; Female; Glucose; Glutamine; Humans | 1994 |
Methionine derivatives diminish sulphide damage to colonocytes--implications for ulcerative colitis.
Topics: Acetamides; Animals; Butyrates; Butyric Acid; Carbon Dioxide; Carbon Radioisotopes; Cells, Cultured; | 1996 |
Metabolic adaptation of terminal ileal mucosa after construction of an ileoanal pouch.
Topics: Adult; Aged; Butyrates; Butyric Acid; Colitis, Ulcerative; Female; Glucose; Glutamine; Humans; Ileum | 1997 |
Thiolmethyltransferase activity in the human colonic mucosa: implications for ulcerative colitis.
Topics: Aged; Butyrates; Butyric Acid; Carbon Dioxide; Colitis, Ulcerative; Colon; Erythrocyte Membrane; Fem | 1997 |
L-carnitine for treatment of distal ulcerative colitis.
Topics: Butyrates; Butyric Acid; Carnitine; Colitis, Ulcerative; Enema; Humans | 1992 |
Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report.
Topics: Acetates; Butyrates; Butyric Acid; Colitis, Ulcerative; Fatty Acids, Volatile; Humans; Propionates; | 1991 |
Selective reduction of fatty acid oxidation in colonocytes: correlation with ulcerative colitis.
Topics: 3-Mercaptopropionic Acid; Animals; Butyrates; Butyric Acid; Carbon Dioxide; Colitis, Ulcerative; Col | 1990 |